Publications by authors named "David W Salzman"

Claim this Profile
M
MicroRNA isomiRs reveal novel pathways linked to disease activity and fibrosis in MASLD.
Christian Brion, Stephen A Hoang, Guangliang Wang, Faridodin Mirshahi, Jessie Ang, David W Salzman

Clin Mol Hepatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models.
Alex McCampbell, Tracy Cole, Amy J Wegener, Giulio S Tomassy, Amy Setnicka, David W Salzman

J Clin Invest· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Non-Coding RNA Journal Club: Highlights on Recent Papers-4.
Daniel Gautheret, Joseph H Taube, Sendurai A Mani, Gaetano Santulli, Diego Cuerda-Gil, David W Salzman

Noncoding RNA· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: The Non-Coding RNA Journal Club: Highlights on Recent Papers-4. Non-Coding RNA 2016, 2, 9.
Daniel Gautheret, Joseph H Taube, Sendurai A Mani, Gaetano Santulli, Diego Cuerda-Gil, David W Salzman

Noncoding RNA· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen withdrawal, increased breast cancer risk and the KRAS-variant.
Terri P McVeigh, Song-Yi Jung, Michael J Kerin, David W Salzman, Sunitha Nallur

Cell Cycle· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-34 activity is modulated through 5'-end phosphorylation in response to DNA damage.
David W Salzman, Kotoka Nakamura, Sunitha Nallur, Michelle T Dookwah, Chanatip Metheetrairut

Nat Commun· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A let-7 microRNA-binding site polymorphism in KRAS predicts improved outcome in patients with metastatic colorectal cancer treated with salvage cetuximab/panitumumab monotherapy.
Zenia Saridaki, Joanne B Weidhaas, Heinz-Josef Lenz, Pierre Laurent-Puig, Bart Jacobs, David W Salzman

Clin Cancer Res· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A germline mutation in the BRCA1 3'UTR predicts Stage IV breast cancer.
Jemima J Dorairaj, David W Salzman, Deirdre Wall, Tiffany Rounds, Carina Preskill

BMC Cancer· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SNPing cancer in the bud: microRNA and microRNA-target site polymorphisms as diagnostic and prognostic biomarkers in cancer.
David W Salzman, Joanne B Weidhaas

Pharmacol Ther· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miRNAs in the spotlight: Making 'silent' mutations speak up.
David W Salzman, Joanne B Weidhaas

Nat Med· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 5' terminal uracil of let-7a is critical for the recruitment of mRNA to Argonaute2.
Kristin M Felice, David W Salzman, Jonathan Shubert-Coleman, Kevin P Jensen, Henry M Furneaux

Biochem J· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
P68 RNA helicase unwinds the human let-7 microRNA precursor duplex and is required for let-7-directed silencing of gene expression.
David W Salzman, Jonathan Shubert-Coleman, Henry Furneaux

J Biol Chem· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis